Qualigen Therapeutics, Inc. Announces management changes. [Yahoo! Finance]
Qualigen Therapeutics, Inc. (QLGN)
Company Research
Source: Yahoo! Finance
On September 25, 2024, the board of directors appointed Campbell Becher as President of the Company, effective immediately. On September 26, 2024, the board of directors appointed Kevin Richardson as Interim Chief Executive Officer and Chief Financial Officer as well as a member of the board of directors. Mr. Richardson has extensive experience in leading strategic and turnaround efforts in various small cap companies. “I am excited to be given the opportunity to lead Qualigen as it embarks on new strategic initiatives that will enhance shareholder value”. Mr. Richardson most recently served as CEO of Sanuwave Health Inc., a medical device startup that Mr. Richardson took from a fledgling operation to $20mm in revenue. New President Campbell Becher shares Mr. Richardson's enthusiasm for the future. “We are entering an exciting time at Qualigen with many potential opportunities ahead. We would like to thank Michael and Chris for their years of leadership and guidance at Qualigen.”
Show less
Read more
Impact Snapshot
Event Time:
QLGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QLGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QLGN alerts
High impacting Qualigen Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
QLGN
News
- Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares [Yahoo! Finance]Yahoo! Finance
- Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred SharesGlobeNewswire
- Qualigen Therapeutics announces management changes Sep. 26, 2024 5:28 PM ET By: Akanksha Khushi , SA News Editor [Seeking Alpha]Seeking Alpha
- Qualigen Therapeutics, Inc. Announces management changes.GlobeNewswire
- Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings PanelGlobeNewswire
QLGN
Sec Filings
- 11/21/24 - Form 8-K/A
- 11/21/24 - Form 8-K
- 11/15/24 - Form 3
- QLGN's page on the SEC website